Total Payments
$844,688
2024 Payments
$87,368
Companies
41
Transactions
987
Medicare Patients
921
Medicare Billing
$128,520
Payment Breakdown by Category
Other$428,635 (50.7%)
Consulting$244,908 (29.0%)
Travel$140,769 (16.7%)
Food & Beverage$27,091 (3.2%)
Research$3,100 (0.4%)
Education$184.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $414,310 | 156 | 49.0% |
| Consulting Fee | $244,908 | 110 | 29.0% |
| Travel and Lodging | $140,769 | 344 | 16.7% |
| Food and Beverage | $27,091 | 367 | 3.2% |
| Honoraria | $9,650 | 4 | 1.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,675 | 1 | 0.6% |
| Unspecified | $3,100 | 1 | 0.4% |
| Education | $184.27 | 4 | 0.0% |
Payments by Type
General
$841,588
986 transactions
Research
$3,100
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $139,059 | 224 | $0 (2022) |
| Incyte Corporation | $135,264 | 125 | $0 (2023) |
| TAIHO ONCOLOGY, INC. | $121,985 | 108 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $72,668 | 54 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $67,847 | 63 | $0 (2024) |
| Eisai Inc. | $43,693 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $39,408 | 36 | $0 (2024) |
| Exelixis Inc. | $33,341 | 51 | $0 (2024) |
| ABBVIE INC. | $28,649 | 23 | $0 (2024) |
| PFIZER INC. | $25,716 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87,368 | 87 | AstraZeneca Pharmaceuticals LP ($14,394) |
| 2023 | $154,496 | 165 | AstraZeneca Pharmaceuticals LP ($50,871) |
| 2022 | $105,001 | 124 | Incyte Corporation ($20,838) |
| 2021 | $148,365 | 131 | Incyte Corporation ($59,630) |
| 2020 | $42,011 | 37 | Incyte Corporation ($13,530) |
| 2019 | $50,630 | 59 | Taiho Oncology, Inc. ($21,079) |
| 2018 | $134,584 | 186 | Lilly USA, LLC ($52,901) |
| 2017 | $122,231 | 198 | Lilly USA, LLC ($65,040) |
All Payment Transactions
987 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | TAIHO ONCOLOGY, INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| 12/31/2024 | TAIHO ONCOLOGY, INC. | — | Food and Beverage | Cash or cash equivalent | $302.50 | General |
| 12/31/2024 | TAIHO ONCOLOGY, INC. | — | Travel and Lodging | Cash or cash equivalent | $269.00 | General |
| 12/31/2024 | TAIHO ONCOLOGY, INC. | — | Travel and Lodging | Cash or cash equivalent | $46.62 | General |
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | ZIIHERA (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,230.00 | General |
| 11/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $64.20 | General |
| 11/22/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $48.00 | General |
| 11/21/2024 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $147.06 | General |
| Category: Surgical Stapling | ||||||
| 11/20/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $6,706.25 | General |
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | ZIIHERA (Drug) | Food and Beverage | In-kind items and services | $146.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nexavar (Drug), Stivarga | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,370.00 | General |
| Category: Oncology | ||||||
| 10/31/2024 | TAIHO ONCOLOGY, INC. | — | Travel and Lodging | Cash or cash equivalent | $563.72 | General |
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,580.00 | General |
| 10/25/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $524.74 | General |
| 10/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $48.98 | General |
| 10/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $34.98 | General |
| 10/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 10/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 10/24/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $233.63 | General |
| 10/24/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $64.00 | General |
| 10/10/2024 | Exelixis Inc. | CABOMETYX (Drug) | Honoraria | Cash or cash equivalent | $1,650.00 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 204 | 300 | $69,283 | $29,523 |
| 2022 | 2 | 217 | 307 | $69,051 | $30,459 |
| 2021 | 2 | 238 | 337 | $75,515 | $36,034 |
| 2020 | 3 | 262 | 337 | $76,297 | $32,504 |
Total Patients
921
Total Services
1,281
Medicare Billing
$128,520
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 105 | 201 | $35,635 | $15,393 | 43.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 99 | 99 | $33,648 | $14,130 | 42.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 108 | 108 | $35,360 | $15,230 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 109 | 199 | $33,691 | $15,229 | 45.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 137 | 137 | $44,525 | $20,242 | 45.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 101 | 200 | $30,990 | $15,792 | 51.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 133 | 133 | $43,225 | $18,509 | 42.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 104 | 174 | $26,622 | $11,265 | 42.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 25 | 30 | $6,450 | $2,730 | 42.3% |
About Richard Kim, M. D
Richard Kim, M. D is a Medical Oncology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609810779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Kim, M. D has received a total of $844,688 in payments from pharmaceutical and medical device companies, with $87,368 received in 2024. These payments were reported across 987 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($414,310).
As a Medicare-enrolled provider, Kim has provided services to 921 Medicare beneficiaries, totaling 1,281 services with total Medicare billing of $128,520. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Tampa, FL
- Active Since 06/16/2006
- Last Updated 12/11/2025
- Taxonomy Code 207RX0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609810779
Products in Payments
- PEMAZYRE (Drug) $126,264
- Lonsurf (Drug) $95,944
- CYRAMZA (Drug) $74,267
- IMFINZI (Biological) $49,074
- Stivarga (Drug) $48,618
- BRAFTOVI (Drug) $47,761
- ERBITUX (Drug) $46,393
- Lenvima (Drug) $43,587
- TIBSOVO (Drug) $22,818
- CABOMETYX (Drug) $19,043
- Nexavar (Drug) $16,103
- Cabometyx (Drug) $9,883
- KEYTRUDA (Biological) $9,293
- FRUZAQLA (Drug) $8,090
- Onivyde (Drug) $7,247
- LYNPARZA (Drug) $6,850
- ONIVYDE (Drug) $5,657
- MONOFERRIC (Drug) $5,179
- SYNDROS (Drug) $4,715
- OPDIVO (Biological) $4,185
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Tampa
Kenneth Shain, M.d, M.D
Medical Oncology — Payments: $394,889
Medical Oncology $394,889
Dr. Julio Chavez, Md, MD
Medical Oncology — Payments: $360,060
Medical Oncology $360,060
Ivan Borrello, M.d, M.D
Medical Oncology — Payments: $338,320
Medical Oncology $338,320
Dr. Jingsong Zhang, M.d, M.D
Medical Oncology — Payments: $254,025
Medical Oncology $254,025
Jonathan Strosberg, Md, MD
Medical Oncology — Payments: $207,211
Medical Oncology $207,211
Dr. Sameh Gaballa, Md, MD
Medical Oncology — Payments: $201,569
Medical Oncology $201,569